IBTROZI
- Product NDC
- 84651-200
- 11-digit product format
- 846510200
- Labeler code
- 84651
- Product ID
- 84651-200_5154bda7-7ab4-4ad4-8fee-7fbe9ea692cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- taletrectinib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Nuvation Bio Inc.
- Application
- NDA219713
- Marketing category
- NDA
- Marketing start
- 2025-06-11
- Substance
- TALETRECTINIB ADIPATE
- Active strength
- 272 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC], Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- IBTROZI
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TALETRECTINIB ADIPATE | 272 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6KLL51GNBG |
| Rxcui | 2716925, 2716931 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 84651-200-30 | IBTROZI | 30 in 1 BOTTLE | CAPSULE | 30 | | 4 |
| 84651-200-90 | IBTROZI | 90 in 1 BOTTLE | CAPSULE | 90 | | 4 |
| 84651-200-90 | IBTROZI | 1 in 1 CARTON | CAPSULE | 1 | | 4 |
| 84651-200-93 | IBTROZI | 3 in 1 CARTON | CAPSULE | 3 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 84651-200-30 | 84651020030 | 30 in 1 BOTTLE | | | | | Historical |
| 84651-200-90 | 84651020090 | 90 in 1 BOTTLE | | | | | Historical |
| 84651-200-93 | 84651020093 | 3 BOTTLE in 1 CARTON (84651-200-93) / 30 CAPSULE in 1 BOTTLE (84651-200-30) | 3 bottle | 2025-06-13 | No | No | Historical |